Capital Flow Monitor · Sponsors · CIK 2041370
Dash Bio, Inc.
56 BROAD STREET, BOSTON, MA, 02109 · 617-249-4472
Other Health Care · Corporation· inc. DELAWARE true 2024
Fit score
—
Offering
$30.0M
Sold
$30.0M
% sold
100.0%
Investors
9
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-14 | D ·current | 506(b) | $30.0M | $30.0M | 100.0% | 9 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
David Johnson — Executive Officer / Director, Boston, MA
9 other raises
- VoltServer Inc. $5.0M of $8.0M · 62.5%
- ONclick Healthcare Inc $3.2M of $3.2M · 100.0%
- Twin City Island Spirits, Inc. $200K of $4.0M · 5.0%
- Nature's Toolbox, Inc. $10.4M of $15.0M · 69.1%
- Chestnut Oak Ridge Coal Opportunity Fund, L.P. $24.5M of $24.7M · 99.5%
- Little Kanawha Coal Opportunity Fund, L.P. $12.9M of $13.4M · 96.4%
- May Fork Coal Opportunity Fund, L.P. $18.7M of $20.3M · 91.9%
- Jack Rock Coal Opportunity Fund, L.P. $36.1M of $36.3M · 99.5%
- Solve Therapeutics, Inc. $48.2M of $120.5M · 40.0%
- Alexander Tallett — Executive Officer / Director, Boston, MA
- Andy Smith — Director, Boston, MA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.